GNIPST BULLETIN 2017

24-03-2017

24th March, 2017 Volume No.: 65 Issue No.: 02

Vision
To develop responsible citizens who would be professionally equipped to think globally and act
locally and become reformers of society to meet the challenges of future.
Mission
To impart high quality pharmaceutical science, technology and management education to the budding
professionals and provide the ambience needed for developing requisite skills to make a mark of
excellence in Education, Research, Business , Industry and achieve highest personal standards.

Contents
Message from PRINCIPAL
Editorial board
Historical article
News Update
Knowledge based Article
Disease Related Breaking News
Upcoming Events
Drugs Update
Campus News
Students Section
Editors Note
Archive

GNIPST Photo Gallery

For your comments/contribution
OR For Back-Issues,
mailto:gnipstbulletin@gmail.com

GURU NANAK INSTITUTE OF PHARMACEUTICAL

SCIENCE AND TECHNOLOGY
Website: http://gnipst.ac.in
24-03-2017

MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the
last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academic
excellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners are
supported in maximizing their potential and talents. Education needs to focus on personalized learning
and instruction, while promoting an education system that is impartial, universally accessible, and meeting
the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order to
achieve their aims. We are all very proud of you, our students, and your accomplishments and look
forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looking
forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in
this direction and fruits of these efforts will be received by our students in the near future. Our Teachers
are committed and dedicated for the development of the institution by imparting their knowledge and play
the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive
challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic
needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the
opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on
this path.

My best wishes to all.

Dr. A. Sengupta

Click here to go at the top

1
 24-03-2017

EDITORIAL BOARD
CHIEF EDITOR DR. ABHIJIT SENGUPTA
EDITOR MS. JEENATARA BEGUM
ASSOCIATE EDITOR MR. DIPANJAN
MANDAL

HISTORICAL ARTICLE
Thomas Hunt Morgan
Thomas Hunt Morgan was an eminent American zoologist and
geneticist. He is known for his legendary experimental analysis of
the fruit fly, after which he formulated the chromosome theory of
heredity. Morgan also demonstrated that genes are connected in a
series on chromosomes, which carry hereditary traits, therefore
kickstarting the modern field of genetics.
He won the 1933 Nobel Prize for Physiology or Medicine for his
extraordinary achievements.
Early Life and Education:
Born in Lexington, Kentucky, on September 25, 1866 to a rich,
influential southern family, Thomas Hunt Morgan earned his B.S.
degree from the State College of Kentucky (now the University of
Kentucky) in 1886, and his Ph.D. degree from the Johns Hopkins
University in 1890. After his doctorate, Morgan joined the faculty
of Bryn Mawr College for a while.
Contributions and Achievements:
Thomas Hunt Morgan was appointed a professor of experimental
zoology at Columbia University in 1904. He established a large
laboratory at this place that was later termed as the Fly Room. In
collaboration with fellow biologist Lilian Morgan and several
other assistants, Morgan studied and highlighted the two specific
characteristics of the fruit fly (Drosophila melanogaster). They
were able to demonstrate the results of mating individual flies
having these specific characteristics. The discovery is regarded as

Click here to go at the top

2
 24-03-2017

the earliest to extend Mendels genetics from the plants into the
animals.
Morgan also extensively studied the field of experimental
embryology. He knew the hypothetical connections between
genetics and development, but was rather unwilling at the time to
reveal those links explicitly.
Morgan won the 1924 Darwin Medal, the 1933 Nobel Prize for
Physiology or Medicine and the 1939 Copley Medal.
Later Life and Death:
Thomas Hunt Morgan continued to work in the laboratory until
his death. He died in Pasadena, California, of a heart failure, on
December 4, 1945. Morgan was 79 years old.

NEWS UPDATE
Clock stars: Astrocytes keep time for brain,
behavior: (24th March, 2017)
Star-shaped cells called astrocytes, long considered boring,
'support cells,' are finally coming into their own. To everyone's
surprise they even play an important role in the body's master
clock, which schedules everything from the release of hormones to
the onset of sleepiness.
Electrical 'switch' in brain's capillary network
monitors activity and controls blood flow: (24th
March, 2017)
New research has uncovered that capillaries have the capacity to
both sense brain activity and generate an electrical vasodilatory
signal to evoke blood flow and direct nutrients to neurons.

Click here to go at the top

3
 24-03-2017

Immunotherapy drug becomes first therapy

approved by FDA for rare skin cancer: (24th
March, 2017)
The U.S. Food and Drug Administration has granted accelerated
approval to the checkpoint inhibitor Bavencio (avelumab) for the
treatment of patients with metastatic Merkel cell carcinoma.
Sniffing out a new strategy against Alzheimer's
disease: (24th March, 2017)
Neurologists are conducting an 18-month clinical trial testing a
type of insulin delivered in a nasal spray which is used to treat
diabetes in some patients in the Study of Nasal Insulin to Fight
Forgetfulness (SNIFF).
New gene discovered associated with Tau, a
common form of brain pathology: (24th March,
2017)
Investigators have reported the discovery of a new gene that is
associated with susceptibility to a common form of brain
pathology called Tau that accumulates in several different
conditions, including Alzheimer's disease, certain forms of
dementia and Parkinsonian syndromes as well as chronic
traumatic encephalopathy that occurs with repeated head injuries.
'Jumonji' protein key to Ewing's sarcoma
rampage: (24th March, 2017)
A new study pinpoints a protein that may be essential to Ewing's
sarcoma metastasis -- when researchers knocked down the protein
KDM3A in Ewing's sarcoma tumor cells, one of a family known as
Jumonji proteins, they also inhibited the cancer's metastatic
ability.

Click here to go at the top

4
 24-03-2017

Neurosurgical practices must evolve and

transform to adapt to rapidly changing
healthcare industry: (24th March, 2017)
Neurosurgeons hoping to successfully navigate the rapidly
changing healthcare industry must advance their strategies and
adapt new ways of thinking in order to continue to thrive in an
evolving environment, say authors of a new report.
Research suggests a possible role for a storm of
'jumping genes' in ALS: (24th March, 2017)
By inserting an amyotrophic lateral sclerosis (ALS)-linked human
gene called TDP-43 into fruit flies, researchers discovered a
potential role for transposons in the disease.
For detail mail to editor

KNOWLEDGE BASED ARTICLE

FDA approves first treatment for rare form of
skin cancer
The U.S. Food and Drug Administration granted accelerated
approval to Bavencio (avelumab) for the treatment of adults and
pediatric patients 12 years and older with metastatic Merkel cell
carcinoma (MCC), including those who have not received prior
chemotherapy. This is the first FDA-approved treatment for
metastatic MCC, a rare, aggressive form of skin cancer.
While skin cancer is one of the most common cancers, patients
with a rare form called Merkel cell cancer have not had an
approved treatment option until now, said Richard Pazdur, M.D.,
acting director of the Office of Hematology and Oncology Products
in the FDAs Center for Drug Evaluation and Research and director
of the FDAs Oncology Center of Excellence. The scientific
community continues to make advances targeting the bodys
immune system mechanisms for the treatment of various types of
cancer. These advancements are leading to new therapieseven in

Click here to go at the top

5
 24-03-2017

rare forms of cancer where treatment options are limited or non-

existent.
According to the National Cancer Institute, approximately 1,600
people in the United States are diagnosed with MCC every year.
While the majority of patients present with localized tumors that
can be treated with surgical resection, approximately half of all
patients will experience recurrence, and more than 30 percent will
eventually develop metastatic disease. In patients with metastatic
MCC, the cancer has spread beyond the skin into other parts of
the body.
Bavencio targets the PD-1/PD-L1 pathway (proteins found on the
bodys immune cells and some cancer cells). By blocking these
interactions, Bavencio may help the bodys immune system attack
cancer cells.
Bavencio received an Accelerated Approval, which enables the
FDA to approve drugs for serious conditions to fill an unmet
medical need using clinical trial data that is thought to predict a
clinical benefit to patients. Further clinical trials are required to
confirm Bavencios clinical benefit and the sponsor is currently
conducting these studies.
Todays approval of Bavencio was based on data from a single-arm
trial of 88 patients with metastatic MCC who had been previously
treated with at least one prior chemotherapy regimen. The trial
measured the percentage of patients who experienced complete or
partial shrinkage of their tumors (overall response rate) and, for
patients with a response, the length of time the tumor was
controlled (duration of response). Of the 88 patients who received
Bavencio in the trial, 33 percent experienced complete or partial
shrinkage of their tumors. The response lasted for more than six
months in 86 percent of responding patients and more than 12
months in 45 percent of responding patients.
Common side effects of Bavencio include fatigue, musculoskeletal
pain, diarrhea, nausea, infusion-related reactions, rash, decreased
appetite and swelling of the limbs (peripheral edema). The most
common serious risks of Bavencio are immune-mediated, where

Click here to go at the top

6
 24-03-2017

the bodys immune system attacks healthy cells or organs, such as

the lungs (pneumonitis), liver (hepatitis), colon (colitis),
hormone-producing glands (endocrinopathies) and kidneys
(nephritis). In addition, there is a risk of serious infusion-related
reactions. Patients who experience severe or life-threatening
infusion-related reactions should stop using Bavencio. Women
who are pregnant or breastfeeding should not take Bavencio
because it may cause harm to a developing fetus or a newborn
baby.
The FDA granted this application Priority
Review and Breakthrough Therapydesignation. Bavencio also
received Orphan Drug designation, which provides incentives to
assist and encourage the development of drugs for rare diseases.
The FDA granted accelerated approval of Bavencio to EMD Serono
Inc.
The FDA, an agency within the U.S. Department of Health and
Human Services, protects the public health by assuring the safety,
effectiveness, and security of human and veterinary drugs, vaccines
and other biological products for human use, and medical devices.
The agency also is responsible for the safety and security of our
nations food supply, cosmetics, dietary supplements, and products
that give off electronic radiation, and for regulating tobacco
products.
Jeenatara Begum
Assistant Professor
GNIPST

DISEASE RELATED BREAKING NEWS

Meningococcal disease Nigeria: (24th March,
2017)
As of 19 March 2017 (epidemiological week 11), a total of 1407
suspected cases of meningitis and 211 deaths (case fatality rate:
15%) have been reported from 40 local government areas (LGAs)
in five states of Nigeria since December 2016. Zamfara, Katsina and

Click here to go at the top

7
 24-03-2017

Sokoto account for 89% of these cases. Twenty-six LGAs from all
five states reported 361 cases in epidemiological week 11 alone.
Twenty-two wards in 15 LGAs have crossed the epidemic
threshold. Three of these LGAs share borders with Niger. NmC is
the predominant serotype in this outbreak.
The most affected age group is 5 to 14 year olds and they are
responsible for about half of reported cases. Both sexes are almost
equally affected.
Read more

UPCOMING EVENTS
Department of Biotechnology (DBT) and Indian Council of
Medical Research (ICMR) sponsored two days National
Conference on Impact of Pharmaceutical Biotechnology on the
future of Medicine will be held at Geetanjali University, Udaipur
on 24th to 25th March, 2017.
9th NIPER (RBL)-C SIR-CDRI symposium on Empowering Drug
Discovery by Pharmaceutical and Clinical Research at NIPER
Raibareli on 24th to 25th March, 2017.

DRUGS UPDATES
Bausch + Lomb And Nicox Announce PDUFA Date
For Novel Glaucoma Candidate Latanoprostene
Bunod: (20th March, 2017)
Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and
TSX: VRX) wholly owned subsidiary, Bausch + Lomb, and Nicox
S.A. (Euronext Paris: FR0013018124, COX) today announced that
the U.S. Food and Drug Administration (FDA) has set a PDUFA
date of August 24, 2017 for its decision on the New Drug
Application (NDA) for latanoprostene bunod ophthalmic solution,
0.024%. Latanoprostene bunod is an intraocular pressure (IOP)
lowering single-agent eye drop dosed once daily, for patients with
open angle glaucoma (OAG) or ocular hypertension (OHT).
Click here to go at the top

8
 24-03-2017

If approved, latanoprostene bunod would be the first nitric-oxide

donating prostaglandin F2 analog for ophthalmic use.
Read more

CAMPUS NEWS
IRIS 2017:
GNIPST is going to organize the cultural fest IRIS 2017 on 5th and
6th April, 2017.
ICMR Sponsored National Seminar at Orisa:
Congratulations to Ranit Kundu who have got first prize in oral
presentation in ICMR sponsored National Seminar at Orissa.
Intra college cricket tournament 2017:
On 21st and 22nd February 2017 GNIPST organized Intra college
cricket tournament.
Congratulations to the winner:
B.Pharm 2nd year
Man of the match:
Soham Ray
Highest wicket Taker:
Shovon Ghosh
Highest run scorer:
Saikat Bera
Sardar Jodh Singh Trophy 2017:
On 17th February 2017 GNIPST participated in Sardar Jodh Singn
Trophy 2017 and played the cricket match against Asansol
Engineering College and GNIT.
Annual Sports Meet 2017:
On 14th and 15th February 2017 GNIPST organized Annual Sports
Meet 2017.
Congratulations to the following winner:
Click here to go at the top

9
 24-03-2017

Flat Race 100 m for Boys:

1st: Suman Ghosh
2nd: Arijit Mitra Thakur
3rd: Arnab Ghosh
Flat Race 100 m for Girls:
1st: Moutan Roy
2nd: Manpreet Kaur
3rd: Kriti Prasad
Flat Race 200 m for Boys:
1st: Suman Ghosh
2nd: Arnab Ghosh
3rd: Abhiraj Pathak
Flat Race 200 m for Girls:
1st: Anjali Mondal
2nd: Moutan Roy
3rd: Kriti Prasad
3 Legged Race:
1st: Aindrila Bhowmick
Anjali Mondal
2nd: Poulami Sarkar
Pamolita Paul
rd
3 : Renu Sha
Sayani Das
Long Jump for Boys:
1st: Abu Sufian
2nd: Saikat Bera
3rd: Arijit Mitra Thakur
Long Jump for Girls:
1st: Sayani Das
2nd: Aindrila Bhowmick
3rd: Anjali Mondal
Click here to go at the top

10
 24-03-2017

Skipping for Girls:

1st: Moutan Roy
2nd: Aindrila Bhowmick
3rd: Anjali Mondal
Shot put for Boys:
1st: Arijit Mitra Thakur
2nd: Bishal Kr. Singh
3rd: Abu Sufian
Shot put for Girls:
1st: Koyel Ghosh
2nd: Aindrila Bhowmick
3rd: Pamolita Paul
Discuss throw for Boys:
1st: Arijit Mitra Thakur
2nd: Monojit Dutta
3rd: Bishal Kr. Singh
Discuss throw for Girls:
1st: Nasrina Mondal
2nd: Aparupa Sinha
3rd: Kriti Prasad
Sack Race 50 m for Boys:
1st: Sneham Sen
2nd: Arijit Mitra Thakur
3rd: Maruf Billa Akunji
Sack Race 50 m for Girls:
1st: Kriti Prasad
2nd: Nasrina Mondal
3rd: Moutan Roy
Relay Race (4x100 m) for Boys:
Winner: Sneham Sen
Abhiraj Pathak
Click here to go at the top

11
 24-03-2017

Arijit Mitra Thakur

Suman Ghosh
Relay Race (4x100 m) for Girls:
Winner: Kriti Prasad
Sayani Das
Nasima Mondal
Sunanda Konar
Go for Goal for Boys:
1st: Abhiraj Pathak
2nd: Arnab Ghosh
3rd: Subhankar Malakar
Balance Race 100 m for Girls:
1st: Aindrila Bhowmick
2nd: Pamolita Paul
3rd: Moutan Roy
Tug of War (Boys):
Winner: Arnab Mondal
Arnab Chakrabarty
Asif Iqbal
Ankit Chowdhury
Arnab Sarkar
Tug of War (Girls):
Winner: Aparupa Sinha
Priya Bardhan Roy
Poulami Sarkar
Pamolita Paul
Moutan Roy
Flat Race for /male Staff:
1st: Dr. Subhendu Bandyopadhyay
2nd: Debabrata Ghosh Dastidar
3rd: Dipanjan Mondal
Click here to go at the top

12
 24-03-2017

Hit the Stamp for Male Staff:

1st: Dipanjan Mondal
2nd: Debabrata Ghosh Dastidar
3rd: Dr. Asis Bala
Hit the Stamp for Female Staff:
1st: Anuranjita Kundu
2nd: Prapti Chakraborty
3rd: Rakhi
Balance Race for Female Staff:
1st: Moumita Chowdhury
2nd: Priyanka Ray
3rd: Jeenatara Begum
Hari Bhanga for Female Staff:
1st: Sumana Roy
2nd: Priyanka Ray
3rd: Rakhi
Tug of War (Female Staff):
Winner: Dr. Sumana Chatterjee
Dr. Sriparna Kundu Sen
Sumana Roy
Jeenatara Begum
Moumita Chowdhury
Jaya Banerjee
Satabdi
Sunknowledge Pvt. Ltd.:
Cngratulations to the students who got the job of Sonknowledge
Pvt. Ltd.
1. Aishwarya Datta
2. Debjani Saha
3. Sayani Banerjee

Click here to go at the top

13
 24-03-2017

4. Priya Dey
5. Anurag T K Baidya
6. Diptarco Singha
7. Soumyadeep Bhattachrya
8. Soumava Bhattacharya
9. Aniruddha Bhar
10. Dibyojyoti Chatterjee
QUIZ organized by GNIDSR:
Congratulations to Pratik Nandi and Bhaskar, who have acquired
2nd position in quiz competition organized by GNIDSR.
Reminiscence 2017:
On 12th February, 2017 GNIPST celebrated Reunion programme.
GPAT 2017:
The following B.Pharm. final year students have qualified, GPAT-
2017. We congratulate them all.
Anjali Mondal
Anurag T K Baidya
Arpita Ghosal
Rudradip Das
Swati Abat
Tanaya Palit
Tanmoy Saha
Cognizant:
Congratulations to the students who got the job of Cognizant..
NBA Accreditation:
NBA has accreditated GNIPST.
Debate competition:
On 19th November, 2016 our student Pratik Nandy and Dippoman
Guha was participated in All India University debate Competition
organized by Calcutta Debate Circle.

Click here to go at the top

14
 24-03-2017

International seminar 2016:

International seminar on Global Advancement in Pharmaceutical
research and startup organized by GNIPST in collaboration with
IPGA was held on 22nd October, 2016 at GNIPST auditorium.
NBA visit:
The experts of National Board of Accreditation or NBA will be
going to visit GNIPST on 24th September and 25th September,
2016.
Freshers welcome programme:
On 12th September GNIPST organized the Freshers welcome
programme Kulrav 2k16.
GNIPST Football Match 2016:
On 31st August and 1st September GNIPST sports club organized a
football match. The winner of the football match was B.Pharm 3rd
year.
Recent Trends in Pharmaceutical Research:
A Science Awareness Programme comprising of seminar on
Recent Trends in Pharmaceutical Research was organized by
GNIPST in collaboration with National Academy of Science India
(NASI) on 30th august, 2016 from 2 pm to 4.30 pm at GNIPST
auditorium. Plantation programme was also organized by Eco club.
Dr. Hemanta Kumar Majumder, gave his valuable lecture on
Modern Biology & its Evolution and Dr. Pijush K Das delivered
his lecture on Site specific Drug Targeting Magic Bullet
approach.
World Photography Day celebration:
On 19th August 2016 GNIPST celebrated World Photography Day
at Dakhineswar.

Click here to go at the top

15
 24-03-2017

Friendly Football Match:

On 15th August 2016 GNIPST organised a friendly football match
with Alumni members.
Farewell 2016:
On 25th May 2016 GNIPST celebrated the farewell programme for
the final year students. Best of luck to all final year students for
their future life.
ALUMNI MEMBERS 2016:
Congratulations to new Alumni Members of GNIPST.
Placement Record 2016:
SL COMPANY NAME NUMBER OF NUMBER OF JOB
NO STUDENT STUDENT PROFILE
APPEARED/APPLIED SELECTED
1 DR. LAL PATH LAB 64 7 Sales,
Marketing and
office assistant
2 APOLLO 36 25 Hospital and
PHARMACY retail chain
pharmacist
3 ABBOTT INDIA 74 03 Sales and
Marketing

4 HETERO DRUGS 18 18 (Waiting Production,

for final QC and QA
interview)
5 ERIS LIFE SCIENCES 01 01 (Joined) Sales and
Marketing

6 JUPITER 05 01 (Joined) Production,

PHARMACEUTICALS QC and QA

7 GOVT PHARMACIST 4 4 (Joined) Hospital

Pharmacist

8 ALCHEMIST EYE 2 2 (Waiting for Hospital

HOSPITAL final Pharmacist
interview)
9 OPTIVAL HEALTH 21 21 Community
SOLUTIONS PVT. Pharmacist
LTD. (MEDPLUS)

Click here to go at the top

16
 24-03-2017

10 NESTLE INDIA LTD 08 02 Nutrition

Officer
Trainee
11 LUPIN 01 01 Sales and
Marketing

12 GSK 05 02 (1 of them Sales and

PHARMACEUTICAL already joined) Marketing
LTD
13 OAK 06 02 (Joined) Sales and
PHARMACEUTICAL Marketing

IPA Bengal Pharma & Healthcare trust scholarship 2016:

Congratulations to Rudradip Das, student of B.Pharm 3rd year has
been awarded IPA Bengal Pharma & Healthcare trust scholarship
2016.
Accreditation by NAAC:
SL. NAME OF STATE CGPA(out GRADE
NO. THE of scale 4)
INSTITUTE
01 Guru Nanak West 2.70 B
Institute of Bengal
Pharmaceutical
Science And
Technology,
Kolkata-700114

GPAT 2016 Result:

The following B.Pharm. final year students have qualified, GPAT-
2016. We congratulate them all.
Aishika Datta
Mainak Chatterjee
Indira Saha
Priyanka De
Aheli Mukherjee
Soumya Guha

Click here to go at the top

17
 24-03-2017

Debanjana Das
Debalina Datta
Evana Patra
Himadrija Chatterjee

IRIS 2016:
GNIPST organized colllege fest IRIS 2016 from 11th to 13th March,
2016.
Result of different events:
Intracollege Quiz competition:
1st: Arani Roy and Dipayan Nath
2nd: Bhaskar Singha and Pratik Nandi
Intracollege Painting competition:
1st: Swagata Paul
2nd: Aviraj Pathak
3rd: Dippyoman Guha
Group Dance Competition:
Karma Group
Intercollege Solo Dance Competition:
1st : Monodipa Ghosh
2nd: Aditya Paul (NIT)
Antaksari Competition:
1st: Sunanda and Aparupa
2nd: Meghna and Joyita
3rd: Arpita and Pami
Intercollege Solo Singing Competition:
1st: Arpita Sarkar
2nd: Arvind Raj (Sudhir Chandra College)
3rd: Priyam Mondal (Supreme College)
Intercollege Band Competition:
1st: D Errors

Click here to go at the top

18
 24-03-2017

2nd: Mukti
3rd: GNIPST band
Fashion:
Best Male: Md. Nadeem Shah
Best Female: Sweta
Best Couple: Md. Nadeem Shah and Susmita Kar
Blood donation Camp 2016:
On 4th March 2016 Social Service club and Alumni Association
of GNIPST organized a Blood donation camp in association with
Association of voluntary Blood Donars, West Bengal.
National Assessment and Accreditation Council (NAAC):
A NAAC peer team completed a three-day inspection (17th
February to 19th February, 2016) of GNIPST to evaluate its
academic credibility and infrastructure on Friday.
Saraswati Puja 2016:
On 13th February 2016 the students of GNIPST celebrated
Saraswati Puja at GNIPST campus.

STUDENTS SECTION
WHO CAN ANS WER FIRS T????

Which day is observed as world sparrow day?

Answer of Previous Issues Image:
Irene and Frederic Joliot Curie

Send your thoughts/

Quiz/Puzzles/games/write-ups or any other
contributions for Students Section& answers
of this Section at gnipstbulletin@gmail.com

Click here to go at the top

19
 24-03-2017

EDITORS NOTE
It is a great pleasure for me to publish the 2nd issue of 65th Volume
of GNIPST BULLETIN. All the followers of GNIPST BULLETIN
are able to avail the bulletin through facebook account GNIPST
bulletin I am very much thankful to all the GNIPST members and
readers who are giving their valuable comments, encouragements
and supports. I am also thankful to Dr. Abhijit Sengupta, Director
of GNIPST for his valuable advice and encouragement. Special
thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar
and Mr. Soumya Bhattacharya for their kind co-operation and
technical supports. Thank you Mr. Soumya Bhattacharya for the
questionnaires of the student section. An important part of the
improvement of the bulletin is the contribution of the readers. You
are invited to send in your write ups, notes, critiques or any kind of
contribution for the forthcoming special and regular issue.
ARCHIVE
OTHERS:
AICTE has sanctioned a release of grant under Research
Promotion Scheme (RPS) during the financial year 2012-13to
GNIPST as per the details below:
a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical
Science & Technology.
b. Principal Investigator: Dr. LopamudraDutta.
c. Grant-in-aid sanctioned:Rs. 16,25000/- only
d. Approved duration: 3 years
e. Title of the project: Screening and identification of potential
medicinal plant of Purulia & Bankura districts of West Bengal
with respect to diseases such as diabetes, rheumatism, Jaundice,
hypertension and developing biotechnological tools for enhancing
bioactive molecules in these plants.

Click here to go at the top

20
 24-03-2017

Activity Clubs of GNIPST:

Name of Club Member Faculty
CULTURAL Ms. Priyanka Ray
DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya
ECO Ms. Sumana Roy
LITERARY AND PAINTING Ms. Jeenatara Begum
PHOTOGRAPHY Ms. Sanchari Bhattacharya and
Mr. Abir Koley
SCIENCE AND INNOVATIVE Mr. Samrat Bose
MODELLING
SOCIAL SERVICES Dr. Asis Bala
SPORTS Mr. Debabrata GhoshDastidar

Click here to go at the top

21